Summary
Researchers conducted a randomized clinical trial to evaluate the efficacy of Shatavari Ghrita eye drops compared to Triphala Ghrita eye drops, both combined with Shatavari Ksheerapaka, in postmenopausal women with ocular surface diseases. The study involved a group of 60 participants, who were treated with the eye drops over a specific period. Results showed that Shatavari Ghrita drops demonstrated significant improvement in symptoms and ocular health compared to Triphala drops. The mechanism may be related to the nutritive and hydrating properties of Shatavari (Asparagus racemosus), which is known for its qualities supporting female health and ocular lubrication. Although the results are promising, the study has limitations, such as the small sample size and the lack of a blinded control group, which may influence the generalizability of the findings.
Key points
- Shatavari Ghrita eye drops showed significant improvement in ocular symptoms in postmenopausal women.
- The study involved 60 participants, with treatment over a specific period.
- Shatavari (Asparagus racemosus) has nutritive properties that may benefit ocular health.
- Limitations include the small sample size and the lack of a blinded control group.
- Triphala Ghrita was used as a comparison but did not show as positive results as Shatavari.
✦ For you
If you are going through menopause and have noticed ocular discomfort, consider observing how your eyes react to different environments and daily habits. Try maintaining good hydration and an environment with adequate humidity. If symptoms persist, seek a qualified healthcare professional for specific guidance.
For practitionersExpand
When considering the treatment of ocular surface diseases in postmenopausal patients, evaluate the inclusion of Shatavari Ghrita in your formulations. The efficacy observed in this study suggests it may be a valuable option to improve ocular health. Be attentive to each patient's individual needs and adjust recommendations as necessary.